Funded Tech Companies
ExeVir Bio
Researching who invested in ExeVir Bio? European Investment Bank joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
ExeVir Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Rijvisschestraat 120
Ghent, 9052
Belgium
Ghent, 9052
Belgium
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
ExeVir is a clinical-stage company developing novel antibody therapies that help patients ward off infectious diseases. Our focus is on protecting populations unable to benefit from vaccines, such as immunocompromised individuals. The versatile VHH platform enables both prevention and treatment of bacterial and viral threats.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/9/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Torsten Mummenbrauer
Company Investors
- European Investment Bank
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs